CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice†.


Journal

Biology of reproduction
ISSN: 1529-7268
Titre abrégé: Biol Reprod
Pays: United States
ID NLM: 0207224

Informations de publication

Date de publication:
01 08 2019
Historique:
accepted: 07 06 2019
received: 17 05 2019
pubmed: 16 6 2019
medline: 30 9 2020
entrez: 16 6 2019
Statut: ppublish

Résumé

More than 1000 genes are predicted to be predominantly expressed in mouse testis, yet many of them remain unstudied in terms of their roles in spermatogenesis and sperm function and their essentiality in male reproduction. Since individually indispensable factors can provide important implications for the diagnosis of genetically related idiopathic male infertility and may serve as candidate targets for the development of nonhormonal male contraceptives, our laboratories continuously analyze the functions of testis-enriched genes in vivo by generating knockout mouse lines using the CRISPR/Cas9 system. The dispensability of genes in male reproduction is easily determined by examining the fecundity of knockout males. During our large-scale screening of essential factors, we knocked out 30 genes that have a strong bias of expression in the testis and are mostly conserved in mammalian species including human. Fertility tests reveal that the mutant males exhibited normal fecundity, suggesting these genes are individually dispensable for male reproduction. Since such functionally redundant genes are of diminished biological and clinical significance, we believe that it is crucial to disseminate this list of genes, along with their phenotypic information, to the scientific community to avoid unnecessary expenditure of time and research funds and duplication of efforts by other laboratories.

Identifiants

pubmed: 31201419
pii: 5519226
doi: 10.1093/biolre/ioz103
pmc: PMC6735960
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

501-511

Subventions

Organisme : NICHD NIH HHS
ID : P01 HD087157
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD088412
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD095341
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Society for the Study of Reproduction.

Références

J Mol Biol. 2001 Jan 19;305(3):567-80
pubmed: 11152613
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12201-6
pubmed: 14526100
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14864-8
pubmed: 14657352
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14869-74
pubmed: 14657366
Nature. 2005 Mar 10;434(7030):234-8
pubmed: 15759005
J Biol Chem. 2006 Mar 3;281(9):5634-9
pubmed: 16407235
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4982-7
pubmed: 16549803
Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1219-23
pubmed: 17227845
FEBS Lett. 2008 Apr 9;582(8):1203-9
pubmed: 18325338
Biol Reprod. 2009 Feb;80(2):358-66
pubmed: 18987332
Nat Med. 2008 Nov;14(11):1197-213
pubmed: 18989307
Mol Cells. 2009 Feb 28;27(2):199-203
pubmed: 19277502
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17055-60
pubmed: 19805151
J Clin Invest. 2010 Apr;120(4):984-94
pubmed: 20364096
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Sci Rep. 2013 Nov 27;3:3355
pubmed: 24284873
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Asian J Androl. 2015 Jan-Feb;17(1):86-93
pubmed: 25248657
Bioinformatics. 2015 Apr 1;31(7):1120-3
pubmed: 25414360
Reproduction. 2015 Nov;150(5):R159-74
pubmed: 26447148
Mol Hum Reprod. 2016 Feb;22(2):69-82
pubmed: 26612782
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7704-10
pubmed: 27357688
Lancet Diabetes Endocrinol. 2017 Jul;5(7):544-553
pubmed: 27395771
Sci Rep. 2016 Aug 17;6:31666
pubmed: 27530713
FEBS Lett. 2016 Oct;590(20):3526-3537
pubmed: 27670266
Development. 2017 Feb 15;144(4):624-634
pubmed: 28087628
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5370-E5378
pubmed: 28630322
Methods Mol Biol. 2017;1630:67-80
pubmed: 28643250
Cell Stem Cell. 2017 Oct 5;21(4):533-546.e6
pubmed: 28985528
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Nat Rev Urol. 2018 May;15(5):287-307
pubmed: 29532805
Nat Rev Urol. 2018 Jun;15(6):369-384
pubmed: 29622783
Nat Rev Urol. 2018 Sep;15(9):535-562
pubmed: 29967387
J Cell Sci. 2018 Oct 11;131(19):
pubmed: 30185526
Nucleic Acids Res. 2019 Jan 8;47(D1):D807-D811
pubmed: 30395283
Nature. 2019 Apr;568(7751):259-263
pubmed: 30944473
Nature. 2019 Apr;568(7751):193-197
pubmed: 30944477
J Biol Chem. 1994 Dec 16;269(50):31845-9
pubmed: 7989357
Development. 1997 Oct;124(20):4121-31
pubmed: 9374408
Bioinformatics. 1998;14(4):378-9
pubmed: 9632836

Auteurs

Yonggang Lu (Y)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Seiya Oura (S)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.

Takafumi Matsumura (T)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.

Asami Oji (A)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.

Nobuyuki Sakurai (N)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Yoshitaka Fujihara (Y)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Keisuke Shimada (K)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Haruhiko Miyata (H)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Tomohiro Tobita (T)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Taichi Noda (T)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Julio M Castaneda (JM)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Daiji Kiyozumi (D)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Qian Zhang (Q)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Laboratory Animal Center, Chongqing Medical University, Chongqing, China.

Tamara Larasati (T)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Samantha A M Young (SAM)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Priority Research Centre for Reproductive Science, Faculty of Science, The University of Newcastle, Callaghan, New South Wales, Australia.

Mayo Kodani (M)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.

Caitlin A Huddleston (CA)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Center for Drug Discovery, Baylor College of Medicine, Houston, Texas, USA.

Matthew J Robertson (MJ)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Advanced Technology Cores, Baylor College of Medicine, Houston, Texas, USA.

Cristian Coarfa (C)

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

Ayako Isotani (A)

Graduate School of Biological Sciences, Nara Institute of Science and Technology, Nara, Japan.

R John Aitken (RJ)

Priority Research Centre for Reproductive Science, Faculty of Science, The University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.

Masaru Okabe (M)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Martin M Matzuk (MM)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Center for Drug Discovery, Baylor College of Medicine, Houston, Texas, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.

Thomas X Garcia (TX)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Center for Drug Discovery, Baylor College of Medicine, Houston, Texas, USA.
Department of Biology and Biotechnology, University of Houston-Clear Lake, Houston, Texas, USA.

Masahito Ikawa (M)

Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Immunology Frontier Research Center, Osaka University, Osaka, Japan.
The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH